Daniel Mascher

1.5k total citations
24 papers, 1.3k citations indexed

About

Daniel Mascher is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Daniel Mascher has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Epidemiology. Recurrent topics in Daniel Mascher's work include Metabolomics and Mass Spectrometry Studies (3 papers), Analytical Chemistry and Chromatography (3 papers) and Metabolism and Genetic Disorders (3 papers). Daniel Mascher is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (3 papers), Analytical Chemistry and Chromatography (3 papers) and Metabolism and Genetic Disorders (3 papers). Daniel Mascher collaborates with scholars based in Austria, Germany and United States. Daniel Mascher's co-authors include Hermann Mascher, Maximilian Zeyda, Thomas M. Stulnig, Matthias Wittassek, J. Angerer, Karin Kypke, W. Lichtensteiger, Margret Schlumpf, Eva Hochbrugger and Bianca Itariu and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Daniel Mascher

22 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Mascher Austria 12 434 312 276 271 241 24 1.3k
W. Thomas Johnson United States 24 391 0.9× 635 2.0× 279 1.0× 479 1.8× 243 1.0× 99 1.8k
Óscar Pérez‐Méndez Mexico 23 245 0.6× 152 0.5× 132 0.5× 410 1.5× 290 1.2× 127 1.9k
Xiuhua Sun China 25 200 0.5× 368 1.2× 149 0.5× 595 2.2× 529 2.2× 95 2.1k
Hsiang‐Tsui Wang Taiwan 20 279 0.6× 72 0.2× 134 0.5× 600 2.2× 63 0.3× 47 1.3k
Jiyoung Bae South Korea 20 172 0.4× 117 0.4× 40 0.1× 443 1.6× 166 0.7× 40 1.2k
Lei Cao China 25 248 0.6× 94 0.3× 103 0.4× 886 3.3× 102 0.4× 108 1.9k
Alvin C. Chan Canada 22 261 0.6× 551 1.8× 44 0.2× 542 2.0× 76 0.3× 40 1.7k
Irina Stoian Romania 18 142 0.3× 144 0.5× 58 0.2× 289 1.1× 94 0.4× 77 1.2k
Akiyo Matsumoto Japan 21 192 0.4× 232 0.7× 83 0.3× 451 1.7× 112 0.5× 90 1.6k
Sridevi Devaraj United States 22 243 0.6× 567 1.8× 36 0.1× 335 1.2× 252 1.0× 33 1.9k

Countries citing papers authored by Daniel Mascher

Since Specialization
Citations

This map shows the geographic impact of Daniel Mascher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Mascher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Mascher more than expected).

Fields of papers citing papers by Daniel Mascher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Mascher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Mascher. The network helps show where Daniel Mascher may publish in the future.

Co-authorship network of co-authors of Daniel Mascher

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Mascher. A scholar is included among the top collaborators of Daniel Mascher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Mascher. Daniel Mascher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mascher, Daniel, et al.. (2025). Evaluation of Plasma Polyethylene Glycol (PEG) Levels in a Healthy Adult Population. International Journal of Toxicology. 44(6). 451–457.
3.
Dabrowska‐Schlepp, Paulina, Andreas Büsch, Jin‐Song Shen, et al.. (2023). Comparison of efficacy between subcutaneous and intravenous application of moss‐aGal in the mouse model of Fabry disease. JIMD Reports. 64(6). 460–467. 3 indexed citations
4.
Rowley, Helen L., et al.. (2017). Determination of the Concentrations of d-amphetamine, Neurotransmitters and Various Metabolites in Microdialysates Taken From the Brains of Freely-moving Rats. Journal of Pharmacological and Toxicological Methods. 88. 191–192. 1 indexed citations
5.
Johnson, Britt, Hermann Mascher, Daniel Mascher, et al.. (2013). Analysis of Lyso-Globotriaosylsphingosine in Dried Blood Spots. Annals of Laboratory Medicine. 33(4). 274–278. 31 indexed citations
6.
7.
Itariu, Bianca, Maximilian Zeyda, Eva Hochbrugger, et al.. (2012). Long-chain n−3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. American Journal of Clinical Nutrition. 96(5). 1137–1149. 191 indexed citations
8.
Mascher, Daniel, et al.. (2012). Sensitive determination of the peptide AP301 – A motif of TNF-α – From human plasma using HPLC–MS/MS. Journal of Chromatography B. 908. 18–22. 6 indexed citations
10.
Schlumpf, Margret, Karin Kypke, Matthias Wittassek, et al.. (2010). Exposure patterns of UV filters, fragrances, parabens, phthalates, organochlor pesticides, PBDEs, and PCBs in human milk: Correlation of UV filters with use of cosmetics. Chemosphere. 81(10). 1171–1183. 368 indexed citations
11.
Lohninger, Alfred, et al.. (2009). Relationship between Carnitine, Fatty Acids and Insulin Resistance. Gyn�kologisch-geburtshilfliche Rundschau. 49(4). 230–235. 7 indexed citations
12.
Mascher, Hermann, Karl Zech, & Daniel Mascher. (2008). Sensitive simultaneous determination of ciclesonide, ciclesonide-M1-metabolite and fluticasone propionate in human serum by HPLC–MS/MS with APPI. Journal of Chromatography B. 869(1-2). 84–92. 26 indexed citations
13.
Steiner, Ilka, Peter Errhalt, Marion Holy, et al.. (2008). Pulmonary pharmacokinetics and safety of nebulized duramycin in healthy male volunteers. Naunyn-Schmiedeberg s Archives of Pharmacology. 378(3). 323–333. 23 indexed citations
14.
Roesner, Jan P., Peter Petzelbauer, Alexander Koch, et al.. (2007). The fibrin-derived peptide Bβ15–42 is cardioprotective in a pig model of myocardial ischemia-reperfusion injury*. Critical Care Medicine. 35(7). 1730–1735. 44 indexed citations
15.
Mascher, Daniel, et al.. (2006). Determination of neomycin and bacitracin in human or rabbit serum by HPLC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 43(2). 691–700. 13 indexed citations
16.
Mascher, Daniel, et al.. (2006). Method development for dihydralazine with HPLC-MS/MS—an old but tricky substance in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 43(2). 631–645. 5 indexed citations
17.
Mascher, Daniel, et al.. (2005). Ultra-sensitive determination of Formoterol in human serum by high performance liquid chromatography and electrospray tandem mass spectrometry. Journal of Chromatography B. 830(1). 25–34. 9 indexed citations
18.
Lohninger, Alfred, Heidrun Karlic, Ayman Tammaa, et al.. (2005). Carnitine in Pregnancy. Monatshefte für Chemie - Chemical Monthly. 136(8). 1523–1533. 2 indexed citations
19.
Zeyda, Maximilian, Marcus D. Säemann, Karl M. Stuhlmeier, et al.. (2005). Polyunsaturated Fatty Acids Block Dendritic Cell Activation and Function Independently of NF-κB Activation. Journal of Biological Chemistry. 280(14). 14293–14301. 115 indexed citations
20.
Mascher, Daniel, Hermann Mascher, Gerhard Scherer, & E. Schmid. (2001). High-performance liquid chromatographic–tandem mass spectrometric determination of 3-hydroxypropylmercapturic acid in human urine. Journal of Chromatography B Biomedical Sciences and Applications. 750(1). 163–169. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026